During the past decade, US Naval Hospital Okinawa conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "US Naval Hospital Okinawa" are "Coronavirus Disease 2019" (1 trials) and "Severe Acute Respiratory Syndrome Coronavirus 2" (1 trials). Many other conditions were trialed in "US Naval Hospital Okinawa" in a lesser frequency.

Most popular intervention types in "US Naval Hospital Okinawa" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-Sars-CoV-2 Convalescent Plasma" (1 trials) and "Remdesivir" (1 trials). Other intervention names were less common.

The vast majority of trials in "US Naval Hospital Okinawa" are 2 trials for "All" genders.

Currently, there are NaN active trials in "US Naval Hospital Okinawa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in US Naval Hospital Okinawa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in US Naval Hospital Okinawa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".